Vanderbilt researchers are working to better design immune therapies that attack tumors without also attacking healthy normal tissue in patients.
https://news.vumc.org/2023/11/17/tumor-antigens-key-to-improving-cancer-immunotherapy-study/
Bill Snyder
Locked
